Meyer Handelman CO Merck & Co., Inc. Transaction History

Meyer Handelman CO

$2.92 Billion
Q3 2024

A detailed history of Meyer Handelman CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Meyer Handelman CO holds 361,973 shares of MRK stock, worth $35.3 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares

361,973

Previous 358,235 1.04%

Holding current value

$35.3 Million

Previous $44.3 Million 7.31%

% of portfolio

1.41%

Previous 1.57%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$111.15 - $128.97 $415,478 - $482,089	3,738 Added 1.04%	361,973 $41.1 Million
Q2 2024 Jul 16, 2024	BUY	$123.8 - $132.96 $593,002 - $636,878	4,790 Added 1.36%	358,235 $44.3 Million
Q1 2024 Apr 11, 2024	BUY	$113.24 - $131.95 $4.03 Million - $4.7 Million	35,620 Added 11.21%	353,445 $46.6 Million
Q4 2023 Jan 17, 2024	SELL	$100.18 - $109.02 $3.69 Million - $4.02 Million	-36,845 Reduced 10.39%	317,825 $34.6 Million
Q3 2023 Nov 06, 2023	BUY	$102.95 - $114.33 $3.81 Million - $4.23 Million	37,000 Added 11.65%	354,670 $36.5 Million
Q2 2023 Jul 21, 2023	SELL	$108.61 - $118.38 $1.29 Million - $1.41 Million	-11,875 Reduced 3.6%	317,670 $36.7 Million
Q1 2023 Apr 11, 2023	SELL	$102.94 - $114.86 $1.67 Million - $1.86 Million	-16,200 Reduced 4.69%	329,545 $35.1 Million
Q4 2022 Jan 25, 2023	SELL	$87.44 - $112.11 $870,028 - $1.12 Million	-9,950 Reduced 2.8%	345,745 $38.4 Million
Q3 2022 Oct 04, 2022	SELL	$84.53 - $94.96 $507,180 - $569,760	-6,000 Reduced 1.66%	355,695 $30.6 Million
Q2 2022 Jul 15, 2022	SELL	$83.49 - $94.64 $100,188 - $113,568	-1,200 Reduced 0.33%	361,695 $33 Million
Q1 2022 Apr 06, 2022	BUY	$73.51 - $82.4 $192,008 - $215,228	2,612 Added 0.72%	362,895 $29.8 Million
Q4 2021 Jan 25, 2022	BUY	$72.28 - $90.54 $108,203 - $135,538	1,497 Added 0.42%	360,283 $27.6 Million
Q1 2021 May 03, 2021	SELL	$68.86 - $81.11 $289,212 - $340,662	-4,200 Reduced 1.16%	358,786 $27.7 Million
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $17,942 - $19,912	250 Added 0.07%	362,986 $29.7 Million
Q3 2020 Oct 28, 2020	SELL	$73.18 - $82.95 $234,176 - $265,440	-3,200 Reduced 0.87%	362,736 $30.1 Million
Q2 2020 Jul 16, 2020	SELL	$70.42 - $80.13 $154,924 - $176,286	-2,200 Reduced 0.6%	365,936 $28.3 Million
Q1 2020 Apr 22, 2020	SELL	$63.36 - $87.82 $262,056 - $363,223	-4,136 Reduced 1.11%	368,136 $28.3 Million
Q4 2019 Jan 23, 2020	SELL	$77.58 - $87.54 $483,323 - $545,374	-6,230 Reduced 1.65%	372,272 $33.9 Million
Q3 2019 Oct 07, 2019	SELL	$76.08 - $82.93 $435,177 - $474,359	-5,720 Reduced 1.49%	378,502 $31.9 Million
Q2 2019 Jul 23, 2019	SELL	$69.84 - $81.59 $891,507 - $1.04 Million	-12,765 Reduced 3.22%	384,222 $32.2 Million
Q1 2019 Apr 30, 2019	SELL	$69.58 - $79.36 $52,185 - $59,520	-750 Reduced 0.19%	396,987 $32.1 Million
Q4 2018 Feb 05, 2019	SELL	$65.24 - $75.71 $665,448 - $772,241	-10,200 Reduced 2.5%	397,737 $30.4 Million
Q3 2018 Nov 06, 2018	SELL	$57.69 - $67.84 $905,733 - $1.07 Million	-15,700 Reduced 3.71%	407,937 $28.9 Million
Q2 2018 Jul 30, 2018	BUY	$50.83 - $59.72 $84,682 - $99,493	1,666 Added 0.39%	423,637 $25.7 Million
Q1 2018 Apr 23, 2018	SELL	$50.96 - $59.23 $100,187 - $116,446	-1,966 Reduced 0.46%	421,971 $23 Million
Q4 2017 Feb 07, 2018	SELL	$51.62 - $61.64 $258,100 - $308,200	-5,000 Reduced 1.17%	423,937 $23.9 Million
Q3 2017 Oct 25, 2017	BUY	$58.67 - $63.13 $25.2 Million - $27.1 Million	428,937	428,937 $27.5 Million

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.

Account

Meyer Handelman CO Merck & Co., Inc. Transaction History